Murakami M, Kobayashi T, Umeda M, Kudo I, Inoue K
Department of Health Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo.
J Biochem. 1988 Dec;104(6):884-8. doi: 10.1093/oxfordjournals.jbchem.a122577.
Monoclonal antibodies which bind specifically to rat platelet phospholipase A2 have been raised. None of them bound to exocrine phospholipase A2 derived from pancreas or snake venom. All antibodies recognized the conformational structure of rat platelet phospholipase A2 supported by intramolecular disulfide bonds, since the reactivity between the antibodies and the enzyme was lost in the presence of 2-mercaptoethanol. One of them, designed MB5.2, inhibited the activity of the platelet phospholipase A2 in a dose-dependent manner. A kinetic study revealed that antibody MB5.2 apparently competed with the substrate for the active site of the enzyme. The other antibodies, designed MD7.1 and ME6.1, inhibited the binding of the enzyme to heparin. The distribution of phospholipases A2 bearing a similar determinant to rat platelet phospholipase A2 was investigated by immunoprecipitation of the enzyme activity or by an immunoblot technique. Among rat tissues, cross-reactivity was observed with phospholipases A2 from spleen, lung, and bone marrow. Extracellular phospholipase A2 detected in the peritoneal cavity of casein-treated rat was also recognized by these antibodies. Furthermore, antibody MD7.1 cross-reacted with rabbit and guinea pig platelet phospholipases A2.
已制备出能特异性结合大鼠血小板磷脂酶A2的单克隆抗体。它们均不与源自胰腺的外分泌磷脂酶A2或蛇毒结合。所有抗体均识别由分子内二硫键维持的大鼠血小板磷脂酶A2的构象结构,因为在2-巯基乙醇存在下,抗体与该酶之间的反应性丧失。其中一种名为MB5.2的抗体以剂量依赖方式抑制血小板磷脂酶A2的活性。动力学研究表明,抗体MB5.2明显与底物竞争该酶的活性位点。另外两种名为MD7.1和ME6.1的抗体则抑制该酶与肝素的结合。通过对酶活性进行免疫沉淀或采用免疫印迹技术,研究了与大鼠血小板磷脂酶A2具有相似决定簇的磷脂酶A2的分布情况在大鼠组织中,观察到与来自脾脏、肺和骨髓的磷脂酶A2存在交叉反应。在经酪蛋白处理的大鼠腹腔中检测到的细胞外磷脂酶A2也被这些抗体识别。此外,抗体MD7.1与兔和豚鼠血小板磷脂酶A2发生交叉反应。